Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2014 2
2019 1
2020 1
2021 10
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.
Serratì S, Di Fonte R, Porcelli L, De Summa S, De Risi I, Fucci L, Ruggieri E, Marvulli TM, Strippoli S, Fasano R, Rafaschieri T, Guida G, Guida M, Azzariti A. Serratì S, et al. Among authors: fasano r. J Exp Clin Cancer Res. 2023 Sep 28;42(1):251. doi: 10.1186/s13046-023-02808-9. J Exp Clin Cancer Res. 2023. PMID: 37759291 Free PMC article.
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.
Di Fonte R, Strippoli S, Garofoli M, Cormio G, Serratì S, Loizzi V, Fasano R, Arezzo F, Volpicella M, Derakhshani A, Guida M, Porcelli L, Azzariti A. Di Fonte R, et al. Among authors: fasano r. Front Cell Dev Biol. 2023 Jun 13;11:1178316. doi: 10.3389/fcell.2023.1178316. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37384250 Free PMC article.
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy.
Porcelli L, Di Fonte R, Pierri CL, Fucci L, Saponaro C, Armenio A, Serratì S, Strippoli S, Fasano R, Volpicella M, Daprile R, Tommasi S, Ressa CM, Guida M, Azzariti A. Porcelli L, et al. Among authors: fasano r. Pharmacol Res. 2022 Aug;182:106323. doi: 10.1016/j.phrs.2022.106323. Epub 2022 Jun 22. Pharmacol Res. 2022. PMID: 35752358 Free article.
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine.
Abdoli Shadbad M, Hemmat N, Khaze Shahgoli V, Derakhshani A, Baradaran F, Brunetti O, Fasano R, Bernardini R, Silvestris N, Baradaran B. Abdoli Shadbad M, et al. Among authors: fasano r. Front Immunol. 2022 Jan 19;12:788211. doi: 10.3389/fimmu.2021.788211. eCollection 2021. Front Immunol. 2022. PMID: 35126356 Free PMC article.
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer.
Alemohammad H, Najafzadeh B, Asadzadeh Z, Baghbanzadeh A, Ghorbaninezhad F, Najafzadeh A, Safarpour H, Bernardini R, Brunetti O, Sonnessa M, Fasano R, Silvestris N, Baradaran B. Alemohammad H, et al. Among authors: fasano r. Biomed Pharmacother. 2022 Feb;146:112516. doi: 10.1016/j.biopha.2021.112516. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906767 Free article. Review.
Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.
Baghbani E, Noorolyai S, Rahmani S, Shanehbandi D, Shadbad MA, Aghebati-Maleki L, Mokhtarzadeh A, Brunetti O, Fasano R, Silvestris N, Baradaran B. Baghbani E, et al. Among authors: fasano r. Biomed Pharmacother. 2022 Jan;145:112370. doi: 10.1016/j.biopha.2021.112370. Epub 2021 Nov 30. Biomed Pharmacother. 2022. PMID: 34862113 Free article.
20 results